Schafer, J. J., Pandit, N. S., Cha, A., Huesgen, E., Badowski, M. E., Sherman, E., . . . Keith, S. (2020). 1044. The Incidence and Severity of Drug interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients. Open Forum Infect Dis.
Citação norma ChicagoSchafer, Jason J., Neha S. Pandit, Agnes Cha, Emily Huesgen, Melissa E. Badowski, Elizabeth Sherman, Jennifer Cocohoba, Ayako Shimada, and Scott Keith. "1044. The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients." Open Forum Infect Dis 2020.
Deismireacht MLASchafer, Jason J., et al. "1044. The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients." Open Forum Infect Dis 2020.